{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:11:58Z","timestamp":1787994718770,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1743-422x-7-369","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T14:34:59Z","timestamp":1294238099000},"source":"Crossref","is-referenced-by-count":5,"title":["An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1"],"prefix":"10.1186","volume":"7","author":[{"given":"Mar\u00eda C","family":"M\u00e9ndez-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M","family":"Rodr\u00edguez-R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s P","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria J","family":"Rey-Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,20]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1172\/JCI34706","volume":"118","author":"MS Cohen","year":"2008","unstructured":"Cohen MS, Hellmann N, Levy JA, DeCock K, Lange J: The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J Clin Invest 2008, 118: 1244-1254. 10.1172\/JCI34706","journal-title":"J Clin Invest"},{"key":"1113_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1742-4690-6-111","volume":"6","author":"L Colin","year":"2009","unstructured":"Colin L, Van Lint C: Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 2009, 6: 111. 10.1186\/1742-4690-6-111","journal-title":"Retrovirology"},{"key":"1113_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0022-2836(92)90975-P","volume":"223","author":"A Hubner","year":"1992","unstructured":"Hubner A, Kruhoffer M, Grosse F, Krauss G: Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural RNA. J Mol Biol 1992, 223: 595-600. 10.1016\/0022-2836(92)90975-P","journal-title":"J Mol Biol"},{"key":"1113_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.clim.2007.08.015","volume":"126","author":"A Boasso","year":"2008","unstructured":"Boasso A, Shearer GM: Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008, 126: 235-242. 10.1016\/j.clim.2007.08.015","journal-title":"Clin Immunol"},{"key":"1113_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1099\/vir.0.19110-0","volume":"84","author":"JB Alimonti","year":"2003","unstructured":"Alimonti JB, Ball TB, Fowke KR: Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J Gen Virol 2003, 84: 1649-1661. 10.1099\/vir.0.19110-0","journal-title":"J Gen Virol"},{"key":"1113_CR6","doi-asserted-by":"publisher","first-page":"10626","DOI":"10.1021\/ja072791b","volume":"129","author":"AP Silverman","year":"2007","unstructured":"Silverman AP, Kool ET: RNA probes of steric effects in active sites: high flexibility of HIV-1 reverse transcriptase. J Am Chem Soc 2007, 129: 10626-10627. 10.1021\/ja072791b","journal-title":"J Am Chem Soc"},{"key":"1113_CR7","first-page":"217","volume":"119","author":"SJ Potter","year":"2004","unstructured":"Potter SJ, Chew CB, Steain M, Dwyer DE, Saksena NK: Obstacles to successful antiretroviral treatment of HIV-1 infection: problems & perspectives. Indian J Med Res 2004, 119: 217-237.","journal-title":"Indian J Med Res"},{"key":"1113_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1747-0285.2007.00514.x","volume":"69","author":"S Chellappan","year":"2007","unstructured":"Chellappan S, Kiran Kumar Reddy GS, Ali A, Nalam MN, Anjum SG, Cao H, Kairys V, Fernandes MX, Altman MD, Tidor B, et al.: Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis. Chem Biol Drug Des 2007, 69: 298-313. 10.1111\/j.1747-0285.2007.00514.x","journal-title":"Chem Biol Drug Des"},{"key":"1113_CR9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.mt.6300116","volume":"15","author":"D Grimm","year":"2007","unstructured":"Grimm D, Kay MA: Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol Ther 2007, 15: 878-888.","journal-title":"Mol Ther"},{"key":"1113_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/QAD.0b013e3282f37489","volume":"22","author":"D Bezemer","year":"2008","unstructured":"Bezemer D, van Sighem A, de Wolf F, Cornelissen M, van der Kuyl AC, Jurriaans S, van der Hoek L, Prins M, Coutinho RA, Lukashov VV: Combination antiretroviral therapy failure and HIV super-infection. AIDS 2008, 22: 309-311. 10.1097\/QAD.0b013e3282f37489","journal-title":"AIDS"},{"key":"1113_CR11","doi-asserted-by":"crossref","unstructured":"Dahl V, Josefsson L, Palmer S: HIV reservoirs, latency, and reactivation: prospects for eradication. Antiviral Res 85: 286-294. 10.1016\/j.antiviral.2009.09.016","DOI":"10.1016\/j.antiviral.2009.09.016"},{"key":"1113_CR12","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1371\/journal.pcbi.0020135","volume":"2","author":"H Kim","year":"2006","unstructured":"Kim H, Perelson AS: Viral and latent reservoir persistence in HIV-1-infected patients on therapy. PLoS Comput Biol 2006, 2: e135. 10.1371\/journal.pcbi.0020135","journal-title":"PLoS Comput Biol"},{"key":"1113_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pharmthera.2005.03.004","volume":"107","author":"RK Leung","year":"2005","unstructured":"Leung RK, Whittaker PA: RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther 2005, 107: 222-239. 10.1016\/j.pharmthera.2005.03.004","journal-title":"Pharmacol Ther"},{"key":"1113_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2165\/11318190-000000000-00000","volume":"23","author":"M Lopez-Fraga","year":"2009","unstructured":"Lopez-Fraga M, Martinez T, Jimenez A: RNA interference technologies and therapeutics: from basic research to products. BioDrugs 2009, 23: 305-332. 10.2165\/11318190-000000000-00000","journal-title":"BioDrugs"},{"key":"1113_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cell.2008.06.034","volume":"134","author":"P Kumar","year":"2008","unstructured":"Kumar P, Ban HS, Kim SS, Wu H, Pearson T, Greiner DL, Laouar A, Yao J, Haridas V, Habiro K, et al.: T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134: 577-586. 10.1016\/j.cell.2008.06.034","journal-title":"Cell"},{"key":"1113_CR16","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1093\/nar\/gkp644","volume":"37","author":"YP Liu","year":"2009","unstructured":"Liu YP, Gruber J, Haasnoot J, Konstantinova P, Berkhout B: RNAi-mediated inhibition of HIV-1 by targeting partially complementary viral sequences. Nucleic Acids Res 2009, 37: 6194-6204. 10.1093\/nar\/gkp644","journal-title":"Nucleic Acids Res"},{"key":"1113_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jgm.1329","volume":"11","author":"KJ von Eije","year":"2009","unstructured":"von Eije KJ, ter Brake O, Berkhout B: Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs. J Gene Med 2009, 11: 459-467. 10.1002\/jgm.1329","journal-title":"J Gene Med"},{"key":"1113_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.ymthe.2006.07.007","volume":"14","author":"O ter Brake","year":"2006","unstructured":"ter Brake O, Konstantinova P, Ceylan M, Berkhout B: Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006, 14: 883-892. 10.1016\/j.ymthe.2006.07.007","journal-title":"Mol Ther"},{"key":"1113_CR19","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/mt.2009.176","volume":"17","author":"YP Liu","year":"2009","unstructured":"Liu YP, von Eije KJ, Schopman NC, Westerink JT, Brake OT, Haasnoot J, Berkhout B: Combinatorial RNAi Against HIV-1 Using Extended Short Hairpin RNAs. Mol Ther 2009, 17: 1712-1723. 10.1038\/mt.2009.176","journal-title":"Mol Ther"},{"key":"1113_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/gt.2008.124","volume":"16","author":"O ter Brake","year":"2009","unstructured":"ter Brake O, Legrand N, von Eije KJ, Centlivre M, Spits H, Weijer K, Blom B, Berkhout B: Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-\/-)gammac(-\/-)) mouse model. Gene Ther 2009, 16: 148-153. 10.1038\/gt.2008.124","journal-title":"Gene Ther"},{"key":"1113_CR21","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1128\/JVI.02035-07","volume":"82","author":"KJ von Eije","year":"2008","unstructured":"von Eije KJ, ter Brake O, Berkhout B: Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J Virol 2008, 82: 2895-2903. 10.1128\/JVI.02035-07","journal-title":"J Virol"},{"key":"1113_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1742-4690-4-80","volume":"4","author":"Y Naito","year":"2007","unstructured":"Naito Y, Nohtomi K, Onogi T, Uenishi R, Ui-Tei K, Saigo K, Takebe Y: Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology 2007, 4: 80. 10.1186\/1742-4690-4-80","journal-title":"Retrovirology"},{"key":"1113_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1742-4690-6-55","volume":"6","author":"GJ McIntyre","year":"2009","unstructured":"McIntyre GJ, Groneman JL, Yu YH, Jaramillo A, Shen S, Applegate TL: 96 shRNAs designed for maximal coverage of HIV-1 variants. Retrovirology 2009, 6: 55. 10.1186\/1742-4690-6-55","journal-title":"Retrovirology"},{"issue":"Suppl 1","key":"1113_CR24","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1186\/1471-2164-10-S1-S9","volume":"10","author":"H Zhou","year":"2009","unstructured":"Zhou H, Zeng X: Energy profile and secondary structure impact shRNA efficacy. BMC Genomics 2009,10(Suppl 1):S9. 10.1186\/1471-2164-10-S1-S9","journal-title":"BMC Genomics"},{"key":"1113_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/nar\/gkh247","volume":"32","author":"K Ui-Tei","year":"2004","unstructured":"Ui-Tei K, Naito Y, Takahashi F, Haraguchi T, Ohki-Hamazaki H, Juni A, Ueda R, Saigo K: Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res 2004, 32: 936-948. 10.1093\/nar\/gkh247","journal-title":"Nucleic Acids Res"},{"key":"1113_CR26","first-page":"156","volume":"11","author":"F Tilesi","year":"2009","unstructured":"Tilesi F, Fradiani P, Socci V, Willems D, Ascenzioni F: Design and validation of siRNAs and shRNAs. Curr Opin Mol Ther 2009, 11: 156-164.","journal-title":"Curr Opin Mol Ther"},{"key":"1113_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-6750-6-7","volume":"6","author":"DJ Taxman","year":"2006","unstructured":"Taxman DJ, Livingstone LR, Zhang J, Conti BJ, Iocca HA, Williams KL, Lich JD, Ting JP, Reed W: Criteria for effective design, construction, and gene knockdown by shRNA vectors. BMC Biotechnol 2006, 6: 7. 10.1186\/1472-6750-6-7","journal-title":"BMC Biotechnol"},{"key":"1113_CR28","doi-asserted-by":"publisher","first-page":"11531","DOI":"10.1128\/JVI.77.21.11531-11535.2003","volume":"77","author":"D Boden","year":"2003","unstructured":"Boden D, Pusch O, Lee F, Tucker L, Ramratnam B: Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003, 77: 11531-11535. 10.1128\/JVI.77.21.11531-11535.2003","journal-title":"J Virol"},{"key":"1113_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-4690-7-52","volume":"7","author":"NC Schopman","year":"2010","unstructured":"Schopman NC, ter Brake O, Berkhout B: Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 2010, 7: 52. 10.1186\/1742-4690-7-52","journal-title":"Retrovirology"},{"key":"1113_CR30","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/JVI.78.5.2601-2605.2004","volume":"78","author":"AT Das","year":"2004","unstructured":"Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R, Berkhout B: Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004, 78: 2601-2605. 10.1128\/JVI.78.5.2601-2605.2004","journal-title":"J Virol"},{"key":"1113_CR31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1089\/aid.2006.22.715","volume":"22","author":"MA Rodriguez-Arenas","year":"2006","unstructured":"Rodriguez-Arenas MA, Jarrin I, del Amo J, Iribarren JA, Moreno S, Viciana P, Pena A, Sirvent JL, Vidal F, Lacruz J, et al.: Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain. AIDS Res Hum Retroviruses 2006, 22: 715-723. 10.1089\/aid.2006.22.715","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1113_CR32","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","volume":"18","author":"DD Richman","year":"2004","unstructured":"Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA: The prevalence of antiretroviral drug resistance in the United States. AIDS 2004, 18: 1393-1401. 10.1097\/01.aids.0000131310.52526.c7","journal-title":"AIDS"},{"key":"1113_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1742-4690-4-78","volume":"4","author":"C Baldwin","year":"2007","unstructured":"Baldwin C, Berkhout B: HIV-1 drug-resistance and drug-dependence. Retrovirology 2007, 4: 78. 10.1186\/1742-4690-4-78","journal-title":"Retrovirology"},{"key":"1113_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1310\/N53E-1930-NJMW-GL7C","volume":"5","author":"AK Sethi","year":"2004","unstructured":"Sethi AK: Adherence and HIV drug resistance. HIV Clin Trials 2004, 5: 112-115. 10.1310\/N53E-1930-NJMW-GL7C","journal-title":"HIV Clin Trials"},{"key":"1113_CR35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3855\/jidc.247","volume":"3","author":"K Bakhouch","year":"2009","unstructured":"Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L: The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naive (HIV1)-infected individuals in Casablanca, Morocco. J Infect Dev Ctries 2009, 3: 380-391. 10.3855\/jidc.247","journal-title":"J Infect Dev Ctries"},{"key":"1113_CR36","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","volume":"15","author":"NK Back","year":"1996","unstructured":"Back NK, Nijhuis M, Keulen W, Boucher CA, Oude Essink BO, van Kuilenburg AB, van Gennip AH, Berkhout B: Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J 1996, 15: 4040-4049.","journal-title":"EMBO J"},{"key":"1113_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2007.12.017","volume":"134","author":"VP Basu","year":"2008","unstructured":"Basu VP, Song M, Gao L, Rigby ST, Hanson MN, Bambara RA: Strand transfer events during HIV-1 reverse transcription. Virus Res 2008, 134: 19-38. 10.1016\/j.virusres.2007.12.017","journal-title":"Virus Res"},{"key":"1113_CR38","first-page":"273","volume":"18","author":"BA Boyle","year":"2008","unstructured":"Boyle BA, Cohen CJ, DeJesus E, Elion R, Frank I, Moyle GJ, Sax P: Update on antiretroviral therapy: the 15th CROI. AIDS Read 2008, 18: 273-278. C273","journal-title":"AIDS Read"},{"key":"1113_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jgm.1078","volume":"9","author":"O ter Brake","year":"2007","unstructured":"ter Brake O, Berkhout B: Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J Gene Med 2007, 9: 743-750. 10.1002\/jgm.1078","journal-title":"J Gene Med"},{"key":"1113_CR40","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/nar\/gkn109","volume":"36","author":"YP Liu","year":"2008","unstructured":"Liu YP, Haasnoot J, ter Brake O, Berkhout B, Konstantinova P: Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res 2008, 36: 2811-2824. 10.1093\/nar\/gkn109","journal-title":"Nucleic Acids Res"},{"key":"1113_CR41","doi-asserted-by":"publisher","first-page":"D237","DOI":"10.1093\/nar\/gkl951","volume":"35","author":"A Marchler-Bauer","year":"2007","unstructured":"Marchler-Bauer A, Anderson JB, Derbyshire MK, DeWeese-Scott C, Gonzales NR, Gwadz M, Hao L, He S, Hurwitz DI, Jackson JD, et al.: CDD: a conserved domain database for interactive domain family analysis. Nucleic Acids Res 2007, 35: D237-240. 10.1093\/nar\/gkl951","journal-title":"Nucleic Acids Res"},{"key":"1113_CR42","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/nar\/27.1.348","volume":"27","author":"RW Shafer","year":"1999","unstructured":"Shafer RW, Stevenson D, Chan B: Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database. Nucleic Acids Res 1999, 27: 348-352. 10.1093\/nar\/27.1.348","journal-title":"Nucleic Acids Res"},{"key":"1113_CR43","volume-title":"Modelo de gesti\u00f3n program\u00e1tica en VIH\/sida","author":"CAD Granados","year":"2006","unstructured":"Granados CAD, \u00c1lvarez C, Prada G, Mart\u00ednez FL, Sarmiento CA: Gu\u00eda para el manejo de VIH\/sida Basada en la evidencia. In Modelo de gesti\u00f3n program\u00e1tica en VIH\/sida. COLOMBIA: Programa de Apoyo a la Reforma de Salud Ajuste a los Planes de Beneficio y la Unidad de Pago por Capitaci\u00f3n. MPS; 2006."},{"key":"1113_CR44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/bioinformatics\/14.9.755","volume":"14","author":"SR Eddy","year":"1998","unstructured":"Eddy SR: Profile hidden Markov models. Bioinformatics 1998, 14: 755-763. 10.1093\/bioinformatics\/14.9.755","journal-title":"Bioinformatics"},{"key":"1113_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","volume":"27","author":"CE Shannon","year":"1948","unstructured":"Shannon CE: A Mathematical Theory of Communication. The Bell System Technical Journal 1948, 27: 379-423. 623-656","journal-title":"The Bell System Technical Journal"},{"key":"1113_CR46","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1073\/pnas.83.24.9373","volume":"83","author":"SM Freier","year":"1986","unstructured":"Freier SM, Kierzek R, Jaeger JA, Sugimoto N, Caruthers MH, Neilson T, Turner DH: Improved free-energy parameters for predictions of RNA duplex stability. Proc Natl Acad Sci USA 1986, 83: 9373-9377. 10.1073\/pnas.83.24.9373","journal-title":"Proc Natl Acad Sci USA"},{"key":"1113_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215: 403-410.","journal-title":"J Mol Biol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-7-369\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-7-369.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T12:10:19Z","timestamp":1559909419000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-7-369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-7-369","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"369"}}